FN1 and chronic myelogenous leukemia, BCR-ABL1 positive: Hypothesizing that replenishing reduced fibronectin levels in mice with BCR-ABL1T315I+ CML may decelerate leukemia progression, we transplanted LIC, resuspended in vehicle or fibronectin, intrafemorally into mice as proof of principle.